AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$492M |
| 2 |
Qualcomm
QCOM
|
+$440M |
| 3 |
Tesla
TSLA
|
+$329M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$308M |
| 5 |
Electronic Arts
EA
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$405M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$313M |
| 3 |
Johnson & Johnson
JNJ
|
+$286M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$275M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$274M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.05% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 12.64% |
| 4 | Consumer Discretionary | 12.44% |
| 5 | Communication Services | 9.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Preferred Bank
PFBC
$1.24B
| $603K | ﹤0.01% |
11,947
-65,852
| -85% | -$2.57M |
|
|
MCFE
2502
DELISTED
McAfee Corp. Class A Common Stock
MCFE
| $603K | ﹤0.01% |
+36,124
| New | +$598K |
|
2503
Prothena Corp
PRTA
$448M
| $602K | ﹤0.01% |
50,140
-4,900
| -9% | -$58K |
|
|
ATRS
2504
DELISTED
Antares Pharma, Inc.
ATRS
| $600K | ﹤0.01% |
150,400
+8,500
| +6% | +$27.5K |
|
2505
REX American Resources
REX
$1.39B
| $598K | ﹤0.01% |
48,834
-744
| -2% | -$9.77K |
|
|
AC
2506
DELISTED
Associated Capital Group
AC
| $597K | ﹤0.01% |
17,003
-200
| -1% | -$7.13K |
|
|
FLNA
2507
Filana Therapeutics
FLNA
$42M
| $597K | ﹤0.01% |
87,500
-37,900
| -30% | -$338K |
|
|
GOOD
2508
Gladstone Commercial Corp
GOOD
$623M
| $594K | ﹤0.01% |
33,001
-10,069
| -23% | -$178K |
|
2509
Oppenheimer Holdings
OPY
$1.18B
| $593K | ﹤0.01% |
18,871
+2,771
| +17% | +$78.1K |
|
2510
Ingles Markets
IMKTA
$1.72B
| $592K | ﹤0.01% |
13,875
-3,478
| -20% | -$134K |
|
|
RUBY
2511
DELISTED
Rubius Therapeutics, Inc
RUBY
| $592K | ﹤0.01% |
78,000
-3,200
| -4% | -$19K |
|
2512
PDF Solutions
PDFS
$1.72B
| $590K | ﹤0.01% |
27,308
-5,200
| -16% | -$109K |
|
2513
W&T Offshore
WTI
$525M
| $590K | ﹤0.01% |
271,844
-27,264
| -9% | -$52.6K |
|
2514
MarineMax
HZO
$748M
| $587K | ﹤0.01% |
16,762
-15,554
| -48% | -$487K |
|
2515
Donnelley Financial Solutions
DFIN
$1.28B
| $586K | ﹤0.01% |
34,550
-13,350
| -28% | -$206K |
|
2516
Turning Point Brands
TPB
$1.48B
| $584K | ﹤0.01% |
13,100
-2,700
| -17% | -$102K |
|
2517
nCino
NCNO
$2.06B
| $582K | ﹤0.01% |
8,033
+690
| +9% | +$53.4K |
|
|
LCI
2518
DELISTED
Lannett Company, Inc.
LCI
| $581K | ﹤0.01% |
22,288
| – | – |
|
|
QADA
2519
DELISTED
QAD Inc.
QADA
| $581K | ﹤0.01% |
9,200
-2,200
| -19% | -$113K |
|
|
CCRN
2520
DELISTED
Cross Country Healthcare
CCRN
| $580K | ﹤0.01% |
65,405
-3,700
| -5% | -$30.1K |
|
2521
Imperial Oil
IMO
$62.3B
| $579K | ﹤0.01% |
30,446
-3,981
| -12% | -$63.8K |
|
2522
Sixth Street Specialty
TSLX
$1.67B
| $578K | ﹤0.01% |
+27,846
| New | +$530K |
|
|
MORF
2523
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $577K | ﹤0.01% |
17,200
-100
| -0.6% | -$2.96K |
|
2524
Rigel Pharmaceuticals
RIGL
$723M
| $573K | ﹤0.01% |
16,374
+1,340
| +9% | +$38.8K |
|
2525
Vanguard Morningstar Small-Cap Growth ETF
VBK
$22.7B
| $573K | ﹤0.01% |
2,142
-34
| -2% | -$8.22K |
|
Similar funds
AllianceBernstein's Q4 2020 Portfolio in Review
As of Q4 2020, AllianceBernstein held 3,270 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
AllianceBernstein's Q4 2020 filing shows 119 new, 863 increased, 1,840 reduced and 111 closed positions. Its largest new stake was Array Technologies: 2,768,125 shares worth $119M. The largest sale was Apple, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q4 2020 buy was Array Technologies: 2,768,125 shares worth $119M.
- AllianceBernstein added most to Amazon in Q4 2020, an estimated $492M increase.
- AllianceBernstein's biggest Q4 2020 reduction was Apple, cutting an estimated $405M.
- AllianceBernstein fully exited Televisa in Q4 2020, selling an estimated $42M.
- AllianceBernstein's ten largest holdings make up 24% of its $212B portfolio in Q4 2020.
- AllianceBernstein opened 119 new positions and closed 111 in Q4 2020.
- AllianceBernstein's portfolio value rose 14% quarter-over-quarter to $212B.
Based on AllianceBernstein's 13F filing for Q4 2020, filed 8 Feb 2021.